Why Healthpeak Properties, Inc. (DOC) stock moved
Healthpeak Properties, Inc. (DOC) shares fell 1.0% to $22.29 as of July 21, 2026, a slight decline from the prior close of $22.51. BestStocks flagged the session as a major change for DOC. No single company-specific catalyst was confirmed during the move window. Below, we break down what changed for DOC, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
DOC fell 1.0% to $22.29
DOC fell 1.0% in its latest session, moving from $22.51 to $22.29.
What it means for Healthpeak Properties, Inc. investors
For Healthpeak Properties, Inc. investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Healthpeak Properties, Inc. (DOC) moved +0.81% from $22.33 to $22.51 on 2026-07-17; Healthpeak Properties, Inc. (DOC) moved +2.71% from $21.74 to $22.33 on 2026-07-16, reaching a new 30-day high. Weighing against that: Negative session, down 1.0%; New SEC filing — review for material disclosures. Wall Street's consensus price target sits at $22.14, implying -0.7% downside from $22.29. Over the past 90 days analysts logged 0 upgrades and 2 downgrades. BestStocks rates the overall signal quality weak (0/100). With earnings roughly 14 days out, the next report is the most likely near-term test of the move.
DOC price reaction
DOC last traded at $22.29, down $0.22 (-0.98%) from the previous close of $22.51. The session traded on 0.7× average volume (below avg), so participation was unremarkable. Over the past month the stock has ranged between $19.98 and $22.51, and it currently sits about 91% of the way up that band.
Bullish and bearish analyst opinions on Healthpeak Properties, Inc. (DOC)
The consensus analyst price target on Healthpeak Properties, Inc. (DOC) is $22.14, 0.7% below the recent $22.29. Over the past 90 days analysts logged 0 upgrades, 13 maintains, and 2 downgrades. Here is how the bullish and bearish cases on DOC line up.
The bullish case
- The Street's most bullish target is $24.00 (+7.7%).
- Healthpeak Properties, Inc. (DOC) moved +0.81% from $22.33 to $22.51 on 2026-07-17.
- DOC moved +0.83% from $21.75 to $21.93 on 2026-07-07.
The bearish case
- The consensus analyst price target of $22.14 sits 0.7% below the recent $22.29, so the average target sees limited room to run.
- The most bearish analyst target is $19.00 (-14.8%).
- 2 analyst downgrades in the past 90 days, most recently Barclays to Equal Weight (2026-07-07).
- Negative session, down 1.0%.
Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Jul 21, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for DOC
Frequently asked questions about DOC
Why did Healthpeak Properties, Inc. (DOC) stock move?
DOC fell 1.0% to $22.29. No single company-specific catalyst was confirmed during the move window, and it looks technical.
How much did DOC stock fall?
DOC lost 0.98% ($0.22) versus the prior close of $22.51, last trading at $22.29 on 0.7× average volume.
When is Healthpeak Properties, Inc.'s next earnings date?
DOC's next earnings report is estimated for 2026-08-04 — about 14 days away.
What is the analyst price target for DOC?
The consensus analyst price target for DOC is $22.14, about 0.7% below the current $22.29. Over the past 90 days, analysts recorded 0 upgrades, 13 maintains, and 2 downgrades.
How BestStocks tracks DOC
This page is generated automatically by BestStocks' change-detection system after its price and volume cleared DOC-specific materiality thresholds, triggering an evidence check. It draws on 6 tracked change events for DOC, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of July 21, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.